William G. Richards - Sep 15, 2023 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Head of Therapeutics Discovery
Signature
/s/ William Richards by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 04:11 PM
Previous filing
Sep 6, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A common Stock Award $0 +344K +163.03% $0.00 555K Sep 15, 2023 Direct F1
transaction ME Class A common Stock Award $0 +116K +20.83% $0.00 671K Sep 15, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ME Stock Option (Right to Buy) Award $0 +166K $0.00 166K Sep 15, 2023 Class A common Stock 166K $1.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units (the "RSUs") under the 23andMe Holding Co. Amended and Restated 2021 Incentive Equity Plan (the "Plan"). The RSUs vest equally in 1/12 quarterly installments commencing on February 20, 2024. The vesting of the RSUs is subject to continued service for 23andMe Holding Co. (the "Company"), the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
F2 Grant of RSUs under the Company's Plan. The RSUs vest in full on August 20, 2024. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
F3 Grant of stock options under the Plan. The stock options vest equally in 1/36 monthly installments commencing on October 15, 2023. The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations.